Inula japonica ameliorated the inflammation and oxidative stress in LPS-induced acute lung injury through the MAPK/NF-κB and Keap1/Nrf2 signalling pathways
Journal of Pharmacy and Pharmacology · 01.02.2023 · 75 (2) · 287-299
DOI: 10.1093/jpp/rgac084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.02.2023. Verfasst von Min Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Inula. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province, Dalian Young Star of Science and Technology.
Abstract (Originalsprache)
Objectives
To investigate the protective effect and underlying mechanism of Inula japonica (TEIJ) in the treatment of acute lung injury (ALI).
Methods
Protective effects of TEIJ in the inflammation and oxidative stress were studied in lipopolysaccharide (LPS)-induced ALI mice. Meanwhile, Western blot and real-time qPCR were carried out to investigate the underlying mechanism of TEIJ for ALI as well as immunohistochemistry. Key findings TEIJ significantly alleviated the course of ALI via suppressing the interstitial infiltrated inflammatory cells, the increase of inflammatory factors and the decrease of anti-oxidative factors. TEIJ inactivated the MAPK/NF-κB signalling pathway to suppress the transcription of its downstream target genes, such as TNF-α, IL-6, etc. Meanwhile, TEIJ activated the Keap1/Nrf2 signalling pathway to regulate expression levels of Nrf2 and its target proteins. The results of LC-QTOF-MS/MS indicated potential active constituents of I. japonica, terpenoids and flavonoids. Additionally, terpenoids and flavonoids synergistically alleviated LPS-induced ALI depending on MAPK/NF-κB and Keap1/Nrf2 signalling pathways.
Conclusion
I. japonica could be considered a potential agent to treat ALI via regulating the MAPK/NF-κB and Keap1/Nrf2 signalling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, College (Institute) of Integrative Medicine, Dalian Medical University, Dalian, China.
- Second Affiliated Hospital, Dalian Medical University, Dalian, China.
- School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Dalian Young Star of Science and Technology
Zitieren
APA
Zhang, M., Zhang, J., Zhu, Q. M., Zhao, W. Y., Lv, X., Yi, J., Huo, X. K., Wang, M. J., & Sun, C. P. (2023). Inula japonica ameliorated the inflammation and oxidative stress in LPS-induced acute lung injury through the MAPK/NF-κB and Keap1/Nrf2 signalling pathways. Journal of Pharmacy and Pharmacology, 75(2), 287-299. https://doi.org/10.1093/jpp/rgac084
Vancouver
Zhang M, Zhang J, Zhu QM, Zhao WY, Lv X, Yi J, et al. Inula japonica ameliorated the inflammation and oxidative stress in LPS-induced acute lung injury through the MAPK/NF-κB and Keap1/Nrf2 signalling pathways. Journal of Pharmacy and Pharmacology. 2023;75(2):287-299. doi:10.1093/jpp/rgac084
BibTeX
@article{Zhang2023,
author = {Zhang, Min and Zhang, Juan and Zhu, Qi-Meng and Zhao, Wen-Yu and Lv, Xia and Yi, Jing and Huo, Xiao-Kui and Wang, Mi-Jia and Sun, Cheng-Peng},
title = {Inula japonica ameliorated the inflammation and oxidative stress in LPS-induced acute lung injury through the MAPK/NF-κB and Keap1/Nrf2 signalling pathways},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
volume = {75},
number = {2},
pages = {287--299},
doi = {10.1093/jpp/rgac084}
}
EUVIMED